For B2B procurement managers in the global veterinary industry—including veterinary distributors, OEM/ODM manufacturers, specialty pet hospitals, and breed-specific retailers—addressing Canine Exocrine Pancreatic Insufficiency (EPI) has become a critical market priority. EPI, a condition characterized by insufficient pancreatic enzyme production, leads to severe malabsorption, weight loss, and digestive distress in dogs, particularly in high-risk breeds like German Shepherds and Collies. Yipai Biotechnology responds with the Nutritional Supplements for Canine EPI Treatment (Yiyi Peptide): a breakthrough formula that merges traditional Chinese medicine (TCM) wisdom with modern enzyme replacement therapy, engineered to provide comprehensive EPI management—designed to meet the rigorous standards of international B2B partners.
Unlike generic Porcine Pancreatic Enzymes for Dogs, this supplement delivers dual-action support: targeted enzyme replacement and natural anti-inflammatory care, integrating Yipai’s patented Pet Ganoderma Nutritional Supplement technology and advanced enzymolysis process. As a core product in our Pet Pancreas Supplements portfolio, it outperforms conventional therapies by addressing both the symptoms and underlying inflammation of EPI. For B2B buyers, it offers three non-negotiable advantages: clinical efficacy (proven enzyme stability and absorption), global quality certification, and scalable supply—key drivers of profitability in the veterinary specialty segment. Below, we break down the product’s technical strengths, application value, and B2B collaboration benefits.
Core Advantages for B2B Procurement
1. Dual-Action Formula (Enzyme Replacement + TCM Support)
The supplement combines porcine-derived digestive enzymes (lipase, protease, amylase) with TCM herbs (Honeysuckle, Magnolia Bark, Dandelion) to address EPI comprehensively. Unlike single-purpose Canine Lipase and Trypsin Enzyme Supplements, it reduces pancreatic inflammation while replacing deficient enzymes—critical for dogs with EPI complicated by pancreatitis. For B2B partners, this versatility expands market reach, catering to veterinary clinics treating both acute and chronic EPI cases.
2. Patented Ganoderma Lucidum Synergy
Yipai’s proprietary Reishi Mushroom for Pets extract (backed by invention patents) enhances immune function and modulates inflammation associated with EPI. This synergy improves gut mucosa integrity, reduces bacterial overgrowth, and boosts nutrient absorption—key for long-term EPI management. For procurement managers, the patented formulation ensures market exclusivity and differentiation from generic enzyme supplements.
3. Enhanced Enzyme Stability & Absorption
- Advanced manufacturing preserves enzyme activity (95%+ stability) during storage and digestion—outperforming conventional supplements prone to degradation.
- Fresh meat enzymolysis technology pre-digests proteins into small-molecule peptides, ensuring optimal nutrient uptake in EPI-affected dogs with compromised digestion.
- Palatability optimization addresses EPI-related appetite loss, improving compliance for end users.
4. Global Quality Certification & Safety Compliance
Manufactured in an FDA-registered facility (Registration No. 13323196228) and ISO 9001:2015 certified, meeting EU/US standards for Veterinary supplements. Each batch undergoes rigorous testing for enzyme activity, purity, and heavy metals—eliminating supply chain risks for B2B partners serving veterinary clinics and specialty retailers.
Target Application Scenarios
The Nutritional Supplements for Canine EPI Treatment solves critical EPI management pain points across B2B segments, driving repeat orders and customer loyalty. Key use cases:
Primary EPI Management
Essential enzyme replacement therapy for daily digestive support in EPI-diagnosed dogs—valued by veterinary clinics and specialty hospitals.
Secondary Pancreatic Conditions
Supports dogs with EPI complicated by pancreatitis, reducing inflammation and improving recovery outcomes—critical for referral veterinary centers.
Breed-Specific Support
Targeted nutrition for EPI-prone breeds (German Shepherds, Collies)—appealing to breeders and specialty breed retailers.
Long-Term Maintenance
Sustainable solution for chronic EPI management, reducing dependency on multiple medications—valued by long-term care facilities and pet owners.
Professional Dosage & Administration
Administer with meals (adjust based on EPI severity and stool quality):
| Dog Weight | Dose per Meal |
| 1-5kg | 3-5ml |
| 5-10kg | 5-8ml |
| ≥10kg | 8-12ml |
B2B Collaboration Benefits
1. OEM/ODM Customization for Veterinary Brands
Yipai offers fully customizable solutions: private labeling (clinic logos, packaging design), formula adjustments (e.g., flavor optimization for compliance), and dosage form modifications. Our R&D team (backed by 2 invention patents and 5 utility models) delivers custom products in 30-45 days, helping you launch exclusive EPI treatment lines in your market.
2. Stable Supply & Competitive Pricing
- MOQ: 500 units (standard); 1,000 units (OEM/ODM)—flexible for small distributors and large veterinary chains.
- Scalable Production: 6 automated lines with 20,000 units/month capacity, ensuring on-time bulk delivery (critical for ongoing EPI treatment protocols).
- Volume Discounts: 10-25% off for orders exceeding 5,000 units, maximizing profit margins for B2B partners.
3. Veterinary-Specific Support & Resources
Receive clinical protocol guides, veterinary training materials, multilingual datasheets (English, German, Spanish), and 24/7 technical support from our veterinary nutrition team. We also provide SEO-optimized content for your B2B website to drive leads in the veterinary specialty segment.
B2B Veterinary Partner FAQ
Q1: Is the product compliant with EU and US veterinary regulations?Yes. It meets EU Feed Additive Regulations (EC 1831/2003) and US FDA requirements for veterinary supplements. Full compliance documentation (certificates, enzyme activity test reports) is provided for customs clearance and veterinary registration.
Q2: Can we request a sample for clinical evaluation?Absolutely. We offer free clinical samples (up to 10 units) for veterinary clinics and hospitals, with shipping costs covered by Yipai. Samples include a detailed usage guide and clinical efficacy data from pilot studies.
Q3: What is the shelf life and storage requirement?Shelf life is 24 months from production (stored at 0-25℃). Airtight, light-resistant packaging preserves enzyme activity, with clear batch/expiry dates for easy inventory management in veterinary facilities.
Q4: How does this product differ from conventional enzyme supplements? Unlike generic enzyme replacements, it integrates Reishi Mushroom for Pets and TCM herbs for anti-inflammatory support, improved gut health, and reduced side effects (e.g., mouth irritation). It also offers higher enzyme stability and palatability—key for long-term EPI management.
Partner with Yipai for Canine EPI Treatment Excellence
Yipai’s Nutritional Supplements for Canine EPI Treatment is a strategic B2B asset for veterinary channels, combining clinical efficacy, scientific innovation, and scalability. It addresses an unmet need in EPI management, driving revenue for distributors and improving patient outcomes for clinics. With our OEM/ODM capabilities and veterinary-specific support, we’re your trusted partner in expanding your specialty pet health portfolio.
Contact our B2B sales team today to request clinical samples, discuss customization, or get a detailed quotation. Let’s elevate EPI treatment standards for dogs worldwide!
